- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
- Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
Key statistics
As of last trade, Omeros Corp (OMER:NMQ) traded at 3.12, 238.59% above the 52 week low of 0.92 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.07 |
---|---|
High | 3.12 |
Low | 3.07 |
Bid | 3.11 |
Offer | 3.12 |
Previous close | 3.06 |
Average volume | 307.50k |
---|---|
Shares outstanding | 57.94m |
Free float | 55.41m |
P/E (TTM) | -- |
Market cap | 177.30m USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 16:20 BST.
More ▼